More names will soon be added to the line-up, stay tuned!

Jean Tirole is chairman of the Toulouse School of Economics (TSE) and the Institute for Advanced Study in Toulouse (IAST), which he helped found in 2011. He is also affiliated with the Massachusetts Institute of Technology, where he holds a visiting position, the Ecole des Hautes Etudes en Sciences Sociales, and the Académie des sciences morales et politiques. Professor Tirole’s research covers industrial organization, regulation, finance, macroeconomics and banking, and psychology-based economics. Jean Tirole has published over two hundred articles in international reviews, as well as twelve scientific books. His latest book entitled Economics for the Common Good, accessible to a wide audience, is under translation into fifteen languages. He is laureate of numerous international distinctions, including the 2007 CNRS gold medal and the 2014 Sveriges Riksbank prize in economic sciences in memory of Alfred Nobel.

Jean-Eric Paquet began his career in the European Commission in 1993 in the Directorate-General for Transport, in the International Relations area, and later as assistant to the Transport Director General , Robert Coleman. In 1999 he joined the office of Mr Verheugen (Member of the European Commission in charge of enlargement). In 2002 he became the deputy head of office of M. Busquin, member of the European Commission in charge of Research policy. Mr Paquet was EU Ambassador in the Islamic republic of Mauritania between 2004 and 2007. He returned to transport in 2007 where he led the development of the Trans-European Transport Network policy. As Director for the “European Mobility Network” he was responsible for Europe’s transport infrastructure policy and investment strategies, the single European rail area, inland waterways and port policy. He joined DG Enlargement in November 2013 where he took over the Directorate in charge of relations with Albania, Bosnia & Herzegovina, Serbia, Kosovo. He took up his present position in January 2015, adding Montenegro and the former Yugoslav Republic of Macedonia to his portfolio. In November 2015 he was appointed Deputy Secretary General of the European Commission responsible for Better Regulation and Policy Coordination (economic governance, internal market and competitiveness, resource efficiency and employment, education and social policies). Since 2018, he is Director General of DG RTD at the European Commission

A scientist by training, Vivienne hosts medical programmes for BBC Radio 4, writes widely on health, presents films, facilitates many high level conferences and debates and trains young researchers. She also has a part time role as head of engagement at Genomics England which is delivering the 100,000 Genomes Project. She is a board member of UK Research & Innovation (UKRI) which is responsible for the UK’s £6 billion research and innovation strategy.

Catherine Geslain-Lanéelle is General Director for the Economic and Environmental Performance of Enterprises at the French Minsitry of Agriculture and Nutrition.
Between 2006 and 2013, she was Executive Director of European Food Safety Authority (EFSA) in Parma (Italy). From 2003 to 2006, she was General Director of Nutrition in the French Ministry of Agriculture and Fisheries. Prior to 2003, she worked for the European Commission in the Ministry of Agriculture.

Andrew McDowell joined the European Investment Bank as Vice-President on 1st September, 2016. He is the first Irish member of the bank’s Management Committee for 12 years.
Prior to joining the European Investment Bank, Andrew McDowell was Economic Advisor to the Taoiseach, Ireland’s Prime Minister, since 2011. He has 20 years of experience in economic policy and public service management. Prior to working for the Taoiseach, Andrew was Chief Economist at the Irish business development agency, Forfás, and European Deputy Editor at the Economist Intelligence Unit. He holds an MBA from the Michael Smurfit Graduate School of Business and studied at John Hopkins University and University College Dublin.

Dr. Nora Alonso has been CEO since its inception when she co-founded Iden Biotchnology, bringing more than 10 years of executive, management and business development experience in the agribiotech sector. She holds a degree in Biology from the University of Navarra in 1999 and PhD in Biology, developed in the Spanish National Research Council (CSIC).
She has completed her scientific training with an MBA and complementary business training in Biotechnology Companies Management (Genome Spain Foundation), Business Development (Biotechnology Industry Organization), IP deals (LES Spain-Portugal), management skills and leadership (Otto Walter International).

Jim Ajioka is co-founder and CSO of the fabric dyeing company Colorifix.  Synthetic biology has been a major focus of Jim’s lab and research at the University of Cambridge. From his work on microbe-based biosensors to detect water contaminants including arsenic and pathogenic viruses, Jim has participated in consultations and working groups at the WHO and UK Research Councils to assess the impact of synthetic biology on global health and dual-use threats.  Recognising the urgent need to implement better practices for sustainable water use, Jim and Colorifix colleagues focused on one of the most polluting industries on the planet: fabric dyeing.
Jim maintains his lab in the Dept. of Pathology as the cutting edge of synthetic biology is still in the academic sphere.  Jim and his colleagues see cross-disciplinary research as the driving force for innovation, so Jim teaches in the Engineering Department as well as in Biological Sciences. As co-chair of the Cambridge Synthetic Biology Strategic Research Initiative, Jim and his Cambridge colleagues believe that the open nature of synthetic biology as it has developed as an engineering discipline, is essential for stimulating economic growth in this sector for the UK and globally.

Dr. Wridzer Bakker studied Chemical Engineering at Delft University of Technology and holds a PhD in the field of Industrial Catalysis. He is also a graduate of Executive Training programs of the INSEAD business school in Fontainebleau, France. Dr. Bakker is recognized internationally as a forward-thinking innovation practitioner. He has a proven track record in bringing new technologies and products to the market. He is (co)owner and managing director of Plantics following a successful position as Business Development Director at AkzoNobel and CEO of the Institute for Sustainable Process Technology (ISPT). He is also co-founder and co-owner of Nedstack Fuel Cell Technology and served on the Executive Board of the European Federation of Chemical Engineering.

Eelco Blum is Vice President of Business Development, Renewable Chemistries at Avantium.
Prior to joining Avantium, Eelco worked for over a decade at Cargill in his native Netherlands, the U.K., South Africa, Belgium, and the U.S. in a variety of roles, mostly focused in strategy- and business development in the biotech & food ingredients arena. At TerraVia, Eelco was responsible for product line management of new-to-the world ingredients such as algae oil, algae butter, and algae DHA. Now, Eelco is tasked with commercializing Avantium’s portfolio of revolutionary renewable chemistry solutions.

Robert Boyd holds the positional of Manager Environment – Alternative Fuels within the Environment department at the International Air Transport Association (IATA).The focus on alternative fuels is aimed to increase the global deployment while addressing policy, economic, sustainability and logistics challenges. He serves as a member of the United Nations ICAO Alternative Fuels Task Force and sits on the advisory board of the Carbon War Room. Prior to joining IATA Robert was the Principal Economist for Virgin Australia Airlines and co-lead of the renewable jet fuel team. After obtaining a bachelor’s degree in Commerce and a post graduate diploma in Applied Finance Robert spent nearly 10 years in banking for both JP Morgan in Australia and Morgan Stanley in London. He earned a Master’s in Business Economics from the University of Queensland, Australia in 2008.

Davide Braghiroli, Product Manager Environmental Innovations in the Cross-Portfolio department, based in Modena, Italy.
Davide is responsible for environment strategy implementation across the Tetra Pak packaging portfolio to increase the sustainability of the companies packaging solutions, such as sourcing and using bio-based polymers, to the minimisation of environmental impact of customer operations.
Working at Tetra Pak since 2009, during which time gaining experience on Quality Systems (ISO standards), Environmental requirements definition and the assessment of development projects, plus ongoing portfolio performance.

Freya joined LanzaTech in 2007 and has worked in various roles throughout the company. Freya is deeply committed to LanzaTech’s mission of creating a carbon smart future. She is a board member of the Low Carbon Fuels Coalition and with LanzaTech was a founding member of below50, the low carbon fuels initiative of the World Business Council for Sustainable Development. Freya oversees Government Relations, Communications and HR at LanzaTech. She holds an MA from Cambridge University.

Henrik Busch-Larsen has been the CEO of Unibio Group since 2012. He has served as an Army Officer, holds a master’s degree in International Business, and is currently enrolled in an MBA program. Henrik Busch-Larsen has 10 years of experience working with Unibio both as a board member, sales and marketing director and now CEO. Before joining the Unibio team, he founded a technology start-up working within applied artificial intelligence. His ambition is to build a strong reputable business around the U-Loop technology and bring Uniprotein®, a bacterial protein to the world market. The main vision for Unibio is to take part in resolving the World’s protein scarcity challenge by decoupling protein production from the fluctuating agriculture and stressed fishing industries, and thus freeing up agricultural land for food for humans rather than feed for animals. In 2015 Unibio won the EY Entrepreneur of the Year in the Life Sciences Category.

Lionel Clarke co-chairs the UK Synthetic Biology Leadership Council (SBLC), having previously chaired the UK Synthetic Biology Roadmap Coordination Group, which issued the UK Synthetic Biology Roadmap in July 2012. His current co-chair on the SBLC is Lord Henley, having previously co-chaired with Lord Willetts, George Freeman, MP and Lord Prior of Brampton. The SBLC oversees implementation and updating of the UK Roadmap, and issued ‘Biodesign for the Bioeconomy’ a Strategic Plan for UK Synthetic Biology 2016. He is an advisory Board member to the UK government’s Business, Environment and Industrial Strategy department (BEIS) developing a strategy for the Bioeconomy as a contribution towards the UK Industrial Strategy. Research Fellowships at the Cavendish Laboratory Cambridge (Trinity College and Peterhouse), and a Royal Society European Research Fellowship in Grenoble, France, followed his graduation in physics from Imperial College London, alongside a teaching diploma from the Royal Academy of Music. He subsequently gained extensive industrial research experience working for Royal Dutch Shell, forming numerous academic and industrial partnerships to take innovative ideas for better fuels and technologies from laboratory through to global markets. He is a visiting professor in the Department of Bioengineering in Imperial College, and holds an honorary chair in the Faculty of Life Sciences at the Manchester Institute of Biotechnology. He holds advisory team and board member/chairman roles in several UK universities, the Engineering and Physical Sciences research council and the Royal Academy of Engineering, and was a contributor to the US National Research Council document ‘Industrialization of Biology’ 2015. He is founder and director of BionerG, a UK-based bio-environmental consultancy company.

Christophe Dardel currently serves as the CEO of EnobraQ, a French synthetic biology start up founded in 2015 leveraging patented pending breakthrough technologies developed within the Toulouse White Biotechnology cluster (TWB). EnobraQ is unlocking the use of CO2 as an industrial fermentation feedstock enabling large commodity chemicals to be produced in a sustainable manner, both economically and ecologically. Before joining EnobraQ in February 2017, Christophe served for seven years as President & CEO of DSM Biomedical in the USA where he was responsible for growing the business’s global activities that included the acquisition of Kensey Nash, a leading regenerative medicine company. Christophe was also a Board Member of Actamax® a DSM/DuPont Joint Venture. Before joining DSM Biomedical in May 2010, Christophe served for eight years as President of DSM Dyneema, the inventor and manufacturer of Dyneema®, the world’s strongest fiber™. In 2003 he was also appointed board member of Nippon Dyneema Co., Ltd – a joint venture of Toyobo and DSM. Prior to joining DSM in 2002, Christophe held several positions within 3M and E. I. du Pont de Nemours. Christophe earned his Masters of Science degree in Computer Science, Electronics and Automation from ESIEA in Paris.

François de Bie is Senior Marketing Director at Total Corbion PLA. In his function he is responsible for all business development activities with brand owners and key converters. Prior to Corbion, François de Bie worked for more then 15 years for the companies GE Plastics and EconCore and coordinated their business development, marketing and sales and product management. He holds a master degree in Mechanical Engineering, specialized in polymers technology from the Eindhoven University of Technology.

Veronique de Bruijn (MSc MBA) is CEO Photanol since 2016. Previously acting as Investment Director at ICOS Capital a Amsterdam based clean tech VC, she co-lead the investment in Photanol and managed the spin-out of the company, build out of the team and realised strategic partnerships with top tier global players such as Akzo Nobel. Prior to this, she raised early-stage funding for 3 start-ups in the capacity of independent advisor and lead operational / engineering teams from the desert of Tunisia, in the mangroves of Nigeria to offshore Canada (and back ).

Born in 1966, Bernard de Galembert holds a Master degree in Economics, with a specialisation in European Affairs.
From 1991 to 1994, he worked as Chief Economic Adviser to the Confederation of European Sugar Manufacturers (CEFS). He wrote two books on EU subsidies and programmes in favour of companies.
From 1994 to 1996, he joined the European Farmers’ Union (COPA-COGECA) where, amongst other things, he was in charge of setting up and managing the Working Group on Forestry and the one on Agro-tourism.
In 1996, he was as the President’s Adviser of the French Landowners’ Federation (FNPA). At the same, he became Director General of a monthly trade magazine. He was later appointed Chief Policy Adviser of the European Landowners’ Organisation (ELO) in 1997.
He joined CEPI as Forest Director in 2002. His competencies covered international (United Nations Forum on Forests, etc.) and European (Forest Europe, European Forestry Strategy, etc.) processes related to forestry, as well as policy areas such as wood supply for the European paper industry, certification of sustainable forestry, illegal logging, renewable energy sources, climate and forests, water and forests, etc.
As of September 2014, he has taken the position of Innovation and Bioeconomy Director. Within that position, he overlooks issues related to bio-based products, research and innovation policies, resource availability, access to markets, access to finances for new businesses and new products. In that position, he took part to the founding of the European Bioeconomy Alliance (EUBA) that gathers 12 European associations active in fields relevant for the bioeconomy. With the support of the Forest-based Sector Technology Platform, of which he is member of the Board, he is also exploring funding opportunities for research and innovation in the pulp and paper industry.
In parallel, he is actively involved in the global forest and paper organisation ICFPA (International Council of Forest and Paper Associations) and member of the Steering Committee of the FAO Advisory Committee for Sustainable Forest Industries (ACSFI).
Bernard de Galembert also dedicates part of his time in CEPI as Social Affairs Director.
Bernard de Galembert is also managing a farmland and a forest company in Burgundy since 2001.

Christoph Eggert studied chemistry at the University of Stuttgart (Germany) and ECPM Strasbourg (France) from 2001 to 2005 followed by PhD studies in polymer chemistry (University of Stuttgart and ETH Zürich (Switzerland)) until 2008.
In the same year he joined the BayerMaterialScience R&D group of the business unit coatings adhesives & specialities (CAS) as a laboratory head, where he developed adhesives systems for medical application before he worked on the field of silane terminated prepolymers.
Since 2014 he works on the development of diisocyanates and polyisocyanates as raw materials for the adhesive and coatings industry.

Laurent Gilbert, Ph.D. is in charge of l’Oréal Sustainable Innovation program for R&I
Mr. Gilbert holds a Doctorate in Physical Sciences from the Ecole Normale Supérieure, Saint-Cloud and a Ph.D in Organic Chemistry from the University of Paris-Sud.
After his thesis in Organic Chemistry, Laurent Gilbert joined Rhône Poulenc where he worked in various fields, from the synthesis of key intermediates for new actives, to process development, and business development before moving to the United States, where he ran Rhodia’s US Corporate Research Center for three years.
In 2002, Dr. Gilbert joined L’Oréal as Director of the International Raw Materials Department. He assumed global responsibility for the development of all new ingredients coming either from external collaborations or those developed internally, as well as responsibility for the Material Sciences laboratories. In 2011 he took the responsibility for the international development of Advanced Research.
Currently, Laurent Gilbert is leading the team in charge of Environmental Research and Sustainable Development and coordinating the implementation of the sustainable innovation commitments of the group as part of its Sharing Beauty with All programs.

Sylvia Gildemyn, PhD. (Ghent University, 2016), currently leads research projects related to microbial CO2-conversions at OWS nv (Ghent, Belgium), and is involved in the research on waste fermentation. She manages the Catalisti-VLAIO project „CAPRA“. Before joining OWS, she performed her PhD research at the Center for Microbial Ecology and Technology under supervision of Korneel Rabaey, and as a visiting scientist at Cornell University (USA, the Angenent Lab). She focused her PhD research on the development of a reactor technology platform for electricity-driven bioproduction from CO2, as well as microbial chain elongation for the production of medium chain carboxylic acids. To date, she (co)-authored 12  peer reviewed A1 publications.

Lori Giver, Ph.D. is the Vice President of Biological Engineering at Calysta. She joined Calysta in 2013 and is responsible for R&D staff and project management. Prior to joining the company, Lori was with Codexis, Inc., where she held a number of positions including Vice President of Systems Biology, Senior Directory of Technology and Innovation, and Manager of Market Development. Prior to Codexis she was head of the Core Technology Group at Maxgyen, Inc.
Dr. Giver has focused her career on the directed evolution of nucleic acids, proteins and organisms. She has chaired several conferences in the field including Enzyme Engineering XXI and Applications for Enzyme Technologies 2013. She is an author on more than 10 scientific publications and over 50 patents and patent applications. She received a Bachelor of Science degree in Molecular and Cell Biology from the University of California-Berkeley and Ph.D in Molecular Cell and Developmental Biology from Indiana University, Bloomington. Dr. Giver did her post-doctoral research at the California Institute of Technology in the laboratory of Dr. Frances Arnold.

Ludwig Goris obtained a Master in Chemistry from Ghent University and completed his PhD in Physics at Hasselt University in 2006. Ludwig has obtained an Executive Master’s degree in Corporate Finance from Vlerick Business School. After successive post-doctoral positions at Stanford and Hasselt University, he became Investment Associate with the Cleantech Investment Practice of Capricorn Venture Partners. In 2013 he took on the role Investment Manager. In that capacity, he follows up the portfolio of the Capricorn Cleantech Fund through various board director and observer roles and is responsible for Capricorn’s future Cleantech investment strategy. He has a particular interest in agricultural & feedstock technologies novel & bio-based chemistry, water purification, industrial biotech and advanced materials.

Mari Granström earned her PhD degree in organic chemistry from the University of Helsinki in 2009. Prior to that, she completed her MSci with Honours Degree (Chemistry) from the Kingston University London in 2004 having spent one year at industry at Kodak in the UK as research assistant. She has always been fascinated by bio-based chemicals and materials since her PhD research which was focusing on the synthesis of novel cellulose derivatives and their applications. One of the examples was complete biobased solar cell system where the photosynthesis of nature was mimic by cellulose-chlorphyll derivative acting as a light harvesting antenna.
She continued her career by joining the BASF in Ludwigshafen where she continued her journey within the biochemical sector by developing new solutions for several different markets. After 4 fruitful years at BASF, she joined Stora Enso Biomaterials as R&D Director to initiate and develop new solutions for new business and market area for the company. She was responsible for biochemical and biorefinery R&D activities first in Helsinki and later in Stockholm and additionally in the US. Lately, she has joined AVALON Industries as Business Development Manager to develop the company’s core HMF technology offering.

Edward is a microbiologist with a PhD in Biochemical Engineering from the University of Manchester Institute of Science and Technology and over 25 years’ experience with anaerobic bacteria. He has pioneered technical improvements in microbial strain improvement and fermentation process development for biotechnology applications contributing to numerous scientific publications and patents.
Edward is also a serial biotech entrepreneur having founded Green Biologics in 2004 and now a world leading fermentation company manufacturing renewable chemicals. More recently (2014), he founded CHAIN Biotech, a microbiome Company focused on development and commercialisation of microbial technology for the production and delivery of biotherapeutics to the gut. Edward participates on the IB Leadership Forum, several NIBB management boards; C1NET and LBNET and the BBSRC advisory panel for Bioenergy and Industrial Biotechnology.

Christoph Eggert studied chemistry at the University of Stuttgart (Germany) and ECPM Strasbourg (France) from 2001 to 2005 followed by PhD studies in polymer chemistry (University of Stuttgart and ETH Zürich (Switzerland)) until 2008.
In the same year he joined the BayerMaterialScience R&D group of the business unit coatings adhesives & specialities (CAS) as a laboratory head, where he developed adhesives systems for medical application before he worked on the field of silane terminated prepolymers.
Since 2014 he works on the development of diisocyanates and polyisocyanates as raw materials for the adhesive and coatings industry.

Renee Henze is the Global Marketing Director for DuPont Biomaterials at DuPont Industrial Biosciences. In addition to developing the strategic marketing direction for the business, Renee leads a team engaged in the downstream sales and marketing for existing and emerging renewably-resourced technologies. Through the development of high performance, renewable biomaterials, the DuPont biomaterials team is solving critical issues for industries as varied as packaging, food and cosmetics to apparel and carpeting, all facing the challenges of greening their supply chains and offering high performance, sustainable choices to their downstream customers.
Renee serves as a Board Trustee for The Montgomery School in Chester Springs, PA and is an Advisory Board Member for Utah State University program in Outdoor Product Design and Development.
Renee’s work with the bio-based fiber, Sorona®, has allowed her to work across the textile value chain while her work with DuPont’s emerging innovations allow her to work closely within the bio-plastics and packaging market space.
Renee has worked in global marketing and business management roles within DuPont for the past 13 years. In her business and marketing management of DuPont’s Omega-3 and Verlasso® business, Renee worked closely with NGO’s, the culinary and food retail community to introduce and sell sustainably raised salmon. Renee has broad experience in traditional and sustainability marketing, new product launch, business development, promotion, channel development, sales and sales management. Prior to Renee’s work with Dupont, she held various international brand management and sales roles at pharmaceutical giant Astra Zeneca.
An outdoor enthusiast, Renee holds a degree in Molecular Biology, an MBA in Marketing and Management and a degree in Environmental Sustainability. She lives in Philadelphia, PA with her husband and son.

Julie Hill has a background in environmental policy and politics. She is presently Chair of the UK-based Waste and Resources Action Programme (WRAP), a charity working to prevent food waste and promote the circular economy. She is also an Independent Board Member of the Consumer Council for Water, which represents water consumers in England and Wales, and Vice Chair of the UK’s Institution of Environmental Sciences. She has previously been Executive Director of Green Alliance (a leading UK NGO), Deputy Chair of the Agriculture and Environment Biotechnology Commission (which was established by the UK Government to lead the public debate on GM crops) and a board member of the Eden Project. She has written extensively on environmental issues, including a popular book, ‘The Secret Life of Stuff’.

Jill Kauffman Johnson is Head of Global Market Development for Algae Ingredients at Corbion, a Netherlands-based global leader in food and bio-based ingredients.
Prior to joining Corbion, Jill was a Principal and Managing Director of California Environmental Associates (CEA), a consulting firm working at the intersection of policy, philanthropy and the private sector to address some of today’s most serious environmental challenges. She was also the founding Director of the Pacific Coast Regional Office of the Ocean Conservancy.
Jill holds a Masters in Public Policy from Harvard University and a BA in Human Biology from Stanford University.

Christian was one of the early investors in CelluComp. In 2011, he became Chief Executive Officer and executive director. Christian came to CelluComp with extensive operational business experience in the clothing/textile industry and a strong knowledge in brand-building, sustainability and social enterprise. Prior to CelluComp, Christian was Chief Executive Officer for EDUN, a company owned by Bono (of U2). 49% of the company was eventually sold to LVMH. Prior to EDUN, Christian was Managing Director at Lacoste for product development and communication worldwide, a position he held for 5 years. Previously, Christian was European Licensing Director for Disney Consumer Products and Director of European purchasing for Polo Ralph Lauren. Christian is a graduate of Princeton University in USA and resides in France with his wife and 5 children.

Dr. Gregor Kosec (Director for Research and Development at Acies Bio) has a primary research focus in bioactive compounds from natural sources: from discovery of novel drug leads to the development of efficient microbial biotechnology-based production processes for commercially relevant pharmaceuticals. He has carried out research in international leading institutions, including the Jožef Stefan Institute (Ljubljana, Slovenia) and San Martin University (Buenos Aires, Argentina) and his post-doctoral training spent in close collaboration with Sanofi-Aventis (Germany). In recent years, he has been working on the application of metabolic/biosynthetic engineering of microbial compound producers. Dr Kosec is actively involved with the Biotechnical faculty of the University of Ljubljana, providing classes in Design of Bioproducts and Metabolic Engineering of Microorganisms for M.Sc. courses. He is also managing the IP-portfolio of Acies Bio and is an inventor on 7 patents/patent applications and co-author on over 20 papers including several very high-impact publications.

Since March 2015 Roman is a scientist at the Netherlands Organisation for Applied Scientific Research, TNO, in the Department of Sustainable Process and Energy Systems. His work is focused on development of electrochemical production processes for bulk and specialty chemicals from renewable resources. Roman has a background in chemical engineering, specialized in electrochemistry. He completed his BSc in Chemical technologies (specialization Electrochemical Engineering) in Georgian Technical University (Tbilisi), then obtained his MSc in Advanced Chemical Engineering from the University of Manchester. In 2015 Roman graduated with a PhD in Chemical Engineering from Delft University of Technology, department of Chemical Engineering, with a work on development of catalysts for PEM Fuel cells.

Kyriakos Maniatis is Principal Administrator in the Directorate General for Energy of the European Commission. He is responsible for technical issues related to biofuels and bioenergy and managed the DG ENER demonstration component on advanced biofuels in the 7th Framework Programme. He contributes regularly to the legislative actions of the European Commission and to the European Technology Innovation Platform – Bioenergy of the EU Strategic Energy Technology Plan. He is responsible for drafting the mandates to CEN for standardisation work related to liquid and gaseous biofuels. In June 2011 Kyriakos initiated the Biofuels FlightPath for Aviation in close coordination with the aviation and biofuels sectors. In 2016 he initiated and chaired the Sub Group on Advanced Biofuels of the Sustainable Transport Forum which yielded valuable and state of the art information on advanced biofuels representing the voice of the industry. Kyriakos also represents the European Commission in the Executive Committee of IEA Bioenergy Implementing Agreement and served as the ExCo Chairman in 2002, 2005-2007. He regularly organizes workshops and conferences on these subjects such as the International Conference on Lignocellulosic Ethanol (6th ICLE) and Algae Europe 2017. He is also the Co-Chair of the tcBiomass conference organised by the Institute of Gas Technology in Chicago.

JJussi Manninen is Executive Vice President at VTT responsible for the business area of Solutions for Natural Resources and Environment. The business area consists of 450 research professionals working in three research areas: Industrial Biotechnology and food solutions, Biomass processing and products, and Sustainable energy and chemical technologies. Jussi moved to VTT from the Ministry of Employment and the Economy of Finland, where he was responsible for the implementation of the Finnish Government’s key projects on the Bioeconomy and Cleantech and the Finnish bioeconomy strategy.
Jussi holds a PhD in Process Integration from University of Manchester Institute of Science and Technology (UMIST). Previously Jussi worked at VTT for 15 years in research, development and innovation management in the fields of energy, the forest sector and the bioeconomy.

Michael O’Donohue works for INRA, France’s National Institute for Agricultural Research. He holds a PhD in protein biochemistry and research experience in the field of enzyme engineering, especially applied to biomass-active enzymes. Michael is based in France’s largest Industrial Biotechnology laboratory (LISBP) in Toulouse and works on xylanases, arabinofuranosidases and cellulases. Michael has coordinated several large projects focused on biorefining, including the FP7 flagship project BIOCORE, which aimed to conceive a multi-feedstock biorefinery concept. Michael is also the current head of INRA’s CEPIA division, which focuses on Science for Food and Biobased Product Engineering. Since 2014, Michael has played an instrumental role in building an infrastructure initiative (IBISBA) in favor of industrial biotechnology. This pan-European project is currently the focus of a H2020 research infrastructure starting community (the IBISBA 1.0 project) and is currently candidate for ESFRI recognition.

Ward Mosmuller joined Royal DSM in 2009. He advises DSM on strategic issues in areas like innovation (biotech, materials) climate & energy, incl. bioeconomy/circular economy. He represents DSM in associations and multi-stakeholder debates. He is cofounder of the € 3.7 billion EU-PPP Bio-based Industries.
He studied Molecular Sciences (Wageningen University), holds a PhD in Bio-organic Chemistry and an MBA. He worked for the Dutch Technology Agency, in several positions, e.g. as manager of innovation programs and the Technical Development Loan scheme (€600 million public loan facility for businesses). He worked for PricewaterhouseCoopers (risk management, Life Sciences). He was director of BioPartner, supporting universities in life science entrepreneurship and setting-up spin-offs. In 2005 Ward started his consultancy SCILS (innovation & technology transfer). He set up several foundations and companies. He is cofounder-director of the Technology Transfer Office of VU University/Medical Centre and founded there a range of spin-off companies.

Emmanuel PETIOT joined Air Liquide where he held various marketing and sales functions (1996-2000). He then joined Dow Chemical (2000-2004) before joining Novozymes, Danish industrial biotechnology company and world leader in enzymes and microorganisms. In nine years (2004-2012) he had several executive positions in marketing, sales and development of industrial partnerships in Europe, the USA and Asia. He was CEO of the French subsidiary of Novozymes that provided operational support group for all of Europe. Before joining DEINOVE, he was Commercial Director of Novozymes North America Inc., the main global market for enzymes

Jim has been a policy analyst at the OECD since 2011. He has previously been an academic and industrial biotechnologist with specialist expertise in the oil industry. His work at the OECD involves policy for industrial biotechnology, synthetic biology, biomass sustainability and marine biotechnology. He is a fellow of the Royal Society of Chemistry and an Associate Fellow of the Institution of Chemical Engineers. He has authored some 300 articles.

Stefan is an organic chemist by education. He obtained his diploma in chemistry at the University of Bonn, Germany, and his PhD at the Technical University of Berlin. After a postdoctoral research stay at Columbia University in New York, he started his professional career at Novartis in Switzerland in the field of drug discovery with a focus on proteases. Stefan then moved on to Evonik as a project manager and process chemist. During this time, he gained extensive experience in managing chemical R&D projects and transferring them to production scale. After spending 3 years in Tokyo, Japan, being responsible for the Asian-Pacific Health Care sales department, he took over his current position in Germany as Vice President, R&D for Evonik Health Care, a business line of Evonik focusing on complex API manufacturing services, pharma and food ingredients and drug delivery technologies.

Alejandro Ríos is the Director of the Sustainable Bioenergy Research Consortium (SBRC) and Professor of Practice at Masdar Institute (MI), a part of Khalifa University of Science and Technology. The SBRC was established by MI and has as its founding members The Boeing Company, Etihad Airways, and UOP-Honeywell, that together with members ADNOC Refining, Safran, GE, and Bauer Resources, are spearheading research in the use of salt water and halophytes for the production of sustainable alternative aviation fuels.
Dr. Rios was the Director of ASA Fuel Services for 11 years, where he oversaw the operation and management of a network of over 60 fuel farms and their associated 2,000+ daily apron into-plane operations. He was the architect of the Plan de Vuelo (Flight Plan) initiative, and currently participates in the biojet fuel chapter of the Mexican Bioenergy Innovation Center (CEMIE) that is promoting the development of a sustainable aviation biofuel industry in Mexico. He was also a key enabler of the BIOjet Abu Dhabi effort that seeks to develop this industry in the UAE.
He holds a Bachelor’s degree in Civil Engineering from the Universidad Iberoamericana in Mexico City, and Masters and Ph. D. degrees in Civil and Environmental Engineering, from Cornell University in Ithaca, NY, USA.

Christophe founded Genomatica in 1998. Since being named CEO in May 2009, he has led Genomatica to widespread recognition as a leader in industrial biotech, with a commercialized first process and plant (for 1,4-butanediol), a second process in early commercialization (for Brontide™ butylene glycol, winner of the ICIS Innovation Award), and multiple leading partners. The company has earned awards for industry impact (ICIS Top40 Power Players six years in a row, and highest rating for sustainability technology in 2017 ICIS survey), engineering (Kirkpatrick Award), science (EPA Presidential Green Chemistry), industry leadership (voted #1 Hottest in renewable chemicals four years in a row by Biofuels Digest), and company culture (The Scientist as a Best Place to Work). Christophe is Chairman Elect for Biocom, the largest advocate organization for California’s life sciences sector; serves on the World Economic Forum Global Agenda Council on Biotechnology; and is a member of YPO, an international leadership organization for chief executives. Christophe holds a Ph.D. in bioengineering from the University of California, San Diego. He received a B.S. in biomedical engineering from Duke University and was honored as a Distinguished Young Alumnus in 2010.

Martin Stephan joined CARBIOS early 2017. As deputy CEO, he is responsible for strategy, business development, investors relations and finance. CARBIOS, a French clean-tech company, listed on the French Euronext Growth stock exchange, have successfully achieved a 5 year and multi-million collaborative R&D program and is now moving to industrialization with 2 disruptive biological innovations bringing solutions for the end-of-life of plastics.
Martin Stephan has made his entire career in the chemical industry. Prior to joining CARBIOS, he held several senior international positions at Du Pont de Nemours, Chemours and at the chemical branch of the French Oil & Gaz major, Total. He worked in France, Germany, Italy and in Switzerland, where he is currently resident.
Martin Stephan holds a Master in Business Economics from HEC in Paris and a BA in Economics from Paris II university.

David Sudolsky is the President and Chief Executive Officer of Anellotech, which is developing the Bio-TCat™ process to produce cost-competitive renewable aromatic chemicals (benzene, toluene and xylenes, “BTX”) from non-food biomass for use in making plastics such as polyester, nylon, polycarbonate, polystyrene, or for renewable transportation fuels.
Anellotech is currently evaluating loblolly pine and eventually other sustainable bio-feedstocks at its seven-story tall TCat-8® pilot plant. Anellotech complements its world-class R&D team with in-depth, long-term alliances with leaders to leverage decades of successful experience in developing and commercializing process technology. IFPEN is Anellotech’s process development and scale-up partner, Johnson Matthey is the company’s catalyst development partner, and Axens is Anellotech’s partner for commercialization, global licensing and technical support. Industry-leading strategic partners in the BTX supply chain, including Suntory and Toyota Tsusho, as well as other confidential strategic investors, have provided funding to Anellotech.
Prior to founding Anellotech, Sudolsky was a business officer or CEO of five biotechnology, specialty pharmaceutical and bioprocessing start-ups, one of which (Dura Pharmaceuticals) was sold for $1.8 billion. Sudolsky has hands-on chemical engineering experience in process design and refinery plant startups with Union Carbide, and work at Booz, Allen & Hamilton. He is a firm believer in environmental education and co-led a successful five-year effort ending in 2011 to build a multi-faceted Eco Center on the roof of a public school in the middle of New York City. David attended Columbia University where he earned an MBA in Marketing and Finance from the University’s Business School and a B.S. in Chemical Engineering.

Sean Sutcliffe has served as Chief Executive of Green Biologics since April 2008, contributing to the company extensive commercial and operational experience across the energy and renewables sector. Prior to joining Green Biologics he was from 2005 Chief Executive of Biofuels Corporation, a UK based biodiesel producer, and from 2007 Chairman of Tidal Generation Limited, a developer of tidal stream devices. Previously Sean worked for BG Group Plc. for 14 years in a variety of roles spanning operations, business development and strategy, most recently as Executive Vice President with responsibility for Corporate Development and New Businesses. Sean is a Chartered Mechanical Engineer with an Engineering degree from Cambridge University and a non executive director of Keit Spectrometers, a company commercialising instruments for manufacturing industries.

Dave has an extensive background at technology companies that include a variety of roles at DuPont and Kraton Polymers. Prior to joining Modern Meadow, Dave spent over a decade at DuPont building and leading a variety of technology organizations that included manufacturing technology, process development, long and short-term chemical and biotechnology research organizations and bioactives strategy in corporate research and development. Dave was most recently the Chief of Staff for the Office of the Chief Science and Technology Officer at DuPont. Prior to DuPont Dave spent time at Kraton Polymers as research scientist. He holds a PhD in Chemistry from Virginia Polytechnic Institute and State University and a Bachelor of Science in Chemistry from Virginia Commonwealth University

Rob is a chemical engineer from Delft University in the Netherlands and has worked both in the corporate, strategy consulting and start-up world in chemicals, process and water technology. Rob has held business management positions with Akzo Nobel and Shell Chemicals, was a founder and CEO of KiOR in the US and worked as CEO for several other start-ups in chemicals and water technology in Europe.
Rob is Investment Manager in the Capircorn Sustainable Chemistry Fund, looking after investments in areas such as synthetic biology, catalysis, enzyme technology, electrification, activation of CO2 as chemicals resource etc. He is boardmember of DMC-BIO in the USA.Rob is also a private investor and board member in HyVent Technology., Reactor-resources Europe, and COOL Separations and advises several start-ups.
Rob has a Master in Chemical Engineering from the Technical University in Delft, followed the Business Program as the Amsterdam School of Finance and has also done the New Board Programme from Neyenrode Business University, developing board members ‘new style’.

Marcel Wubbolts holds a PhD from the department of Biochemistry, University of Groningen, NL, and was Post- Doctoral research associate and subsequently Assistant Professor at the Institute of Biotechnology at the ETH in Zürich, CH leading a research group on biocatalyst development and remained there until late 1997.
Following his positions in academia, he joined the Life Sciences and Material Sciences company DSM in Geleen, where he has held several positions including that of Chief Technology Officer.
As Chief Technology Officer, Marcel is responsible for Corbion’s global Science and Innovation portfolio. He is passionate about developing sustainable solutions, in conjunction with partners from academia and industry.

Since 2008 John has been with the medical technology trade association, MedTech Europe, where, as Director Regulations and Industrial Policy, he developed and implemented regulatory and industrial policy and advocacy strategy. John left MedTech Europe in 2017 to join EuropaBio as Secretary General.
Before that he spent four years at the European Commission working in the Unit responsible for the European Cosmetics and Medical devices legislation. During his time at the Commission he also had particular experience in international regulatory cooperation. John has over 25 years’ experience both on the regulator and the industrial sides of the healthcare industry.
Prior to coming to Brussels John worked in the Irish National Standards Authority, NSAI, (9 years). Here his responsibilities included managing NSAI’s ‘Notified Body’ activities gaining him extensive European and international experience in the design and quality systems approval of high-risk medical devices and standards development. He began his career in the industry with six years’ experience spanning the in vitro diagnostic, pharmaceutical and medical device industries.
John is a science graduate from Dublin, Ireland, with added post-graduate studies in quality control and environmental engineering.

Prof. Ludo Diels, Dr. in chemistry & biotechnology, works at the University of Antwerp, and is research manager Sustainable Chemistry for the Flemish Institute for Technological Research (VITO) in Mol, Belgium.
During 15 year he managed the Environment and Process Technology Business Unit and is now responsible for the transition toward sustainable chemistry and clean technology. He is responsible for the organisation of collaboration with the academic and industrial World and for co-financing projects. He coordinated and is involved in many international research projects. Ludo Diels is strongly involved in the set up of a biobased economy in Flanders. He is also responsible for the collaboration between VITO and India and he is managing the creation of a road map and Strategic Research Agenda for R&D on biomass and biowaste between India and Europe. He is a founding father of the Shared Research Centre on Bio-aromatics (BIORIZON) between the Netherlands and Flanders. He is also founder and Flanders coordinator of the BIG-C trilateral alliance between Flanders, the Netherlands and NordRhein Westfalia (Germany), focusing on a border denying collaboration for the chemical industry with focus on waste gases and biomass as renewable resources . He is case leader for bio-aromatics in the Vanguard Initiative, pilot Bio-economy, leading to smart specialisation of interregional collaboration.
He is the chairman of the working group FEED in the Energy and Resources PPP-SPIRE between 8 industrial sectors and the European Commission) and member of the SPIRE-BBI working group.

Joanna took on her role of Deputy Secretary-General at EuropaBio in March this year. She previously held the position of Industrial Biotechnology and Cross-Sector Strategy Director in the association. She has over fifteen years of Brussels-based experience in Public Affairs and Strategic Communications and has an academic background in Environmental Science. Prior to joining EuropaBio, Joanna worked in consultancy in the energy, environment, health and development sectors advising a broad range of Fortune 500 companies, industry associations and NGOs and has also worked for the European Commission’s Directorate General for the Environment.

Ian started his career with ICI, a former UK based multinational in chemicals and related sectors. In 1998, he joined DuPont and held during a period of 17 years, several leading positions within the Company. He retired from the Company in 2016 after serving 10 years as President Europe Middle East & Africa. The year after, he joined Carbios’ Board of Directors. Ian also served as a member of the Executive Committee and Board of CEFIC and of EuropaBio. He was also a member of the Foundation Board of IMD and a member of the Swiss-American Chamber of Commerce. Ian HUDSON graduated from Oxford University with an MA degree in French and German.

Yvon Le Hénaff, graduated engineer from AgroParisTech, started his career in 1977 as a R&D Engineer. Then, he held different positions as industrial and commercial director in process engineering and contracting companies in the field of agro industry, in France and abroad (USA, Asia, Russia, Middle East, Iran …).
He was appointed General Manager of ARD in 2002. Under his management, this Research and Development company whose core business is the design and scaling up of process in plant refining, white biotechnology and green chemistry, acquired a worldwide reputation. It now operates for industrial companies and start up such as Corbion, Amyris, Global Bio Energies,… and has been founding shareholder of Soliance, producing actives ingredients out of plant for the cosmetic industry, recently taken over by Givaudan group, and of BioAmber for which it did design and scale up on its industrial demonstration plant the succinic acid production process.
He retired in July 2018 after 16 years as General Manager.
Yvon Le Hénaff is President of the Industry and Agro-resource (IAR) Cluster, Member of the UIC’s (Union of Chemical Industries) Innovation Commission and Vice President of the UIC Picardie Champagne-Ardenne.

Professor Pierre Monsan earned his engineering degree in Biological Chemistry (1969) from the National Institute for Applied Sciences (INSA), University of Toulouse, France, as well as his Doctor-Engineer Degree (1971) and his PhD degree (1977). He obtained a Lecturer position in the Department of Biochemical Engineering at INSA in 1969, and was promoted Assistant Professor in 1973 and Full Professor in 1981.
He founded one of the very first French start-up companies, BioEurope, focusing on the field of Biocatalysis in 1984. In 1993, BioEurope merged with the Solabia Group. He returned to INSA to create the Gilbert Durand Bioengineering Center and to start a new research group focusing on enzyme molecular engineering with Prof. Magali Remaud-Simeon. He was appointed Professor at Ecole des Mines Paris in 1993. He was involved in the creation of BioTrade in 1996 and of GeniBio in 1998. From 1999 to 2004 he headed the Department of Biochemical Engineering at INSA. He was elected member of the French University Institute (IUF) in 2003 and re-elected in 2008.
He founded Toulouse White Biotechnology (TWB) in 2012 with a €20m grant from the French Government. He is presently Professor Emeritus at INSA and Director of TWB.
Professor Monsan has made many significant contributions to the field of enzyme engineering. His early work was on enzyme immobilization and enzyme reactor development. He elucidated the mechanism of action of glutaraldehyde, one of the most widely used reagents for enzyme covalent binding. In the late 70s, he was one of the very first researchers to use enzymes in non-aqueous media to “transform” hydrolytic enzymes into synthetic enzymes for ester, amide and glycosidic linkage synthesis. His group at INSA has made very significant contributions to the field of glucansucrases.
Professor Monsan is the author of more than 240 publications, 3 books and 65 patents. Also, he is Chairman of the French Federation of Biotechnology and a member of:
the French Academy of Technology,
the French Academy of Agriculture,
the “College of Fellows” of the American Institute for Medical and Biological Engineering (AIMBE),
the Executive Board of the European Federation of Biotechnology.

Professor Kevin O Connor is a member of the school of Biomolecular and Biomedical Science and the Earth Institute at University College Dublin, Ireland. He is chairperson of the scientific committee for the public private partnership Biobased Industries Joint Undertaking (BBI JU), a member of the European Commission biobased products expert group and a previous member of European Commission committee entitled the “lead market initiative for Bio-based products (2008-2011). His research interests are integrated biorefining, Biobased chemicals, biodegradable polymers, biocatalysis and protein engineering. Professor O Connor has published over 85 international peer review articles and made of over 170 contributions (presentations and posters) at national and International conferences. He has filed 8 patents and successfully licensed 3 technologies resulting from his research work. Professor Kevin O’ Connor is the founder of Bioplastech a university spin out company endeavouring to commercialise the conversion of residues and biobased resources to biodegradable polymers.

Neil obtained his first degree in Biology at Portsmouth University in 1993. In his final year he majored in enzymology and this sparked the interest here and shaped his resulting career. Neil completed his PhD in Industrial Biotechnology in ’96 involving every aspect of the protein engineering cycle and this provided the opportunity to work in a number of EU labs and industry groups as part of the consortium. In Unilever Neil worked on enzymes and protein technology for the chemical businesses and the antibody company Unipath. He held project leader posts in Biorecognition and Life Sciences divisions and was part of teams making key inventions in exploitation of protein domains in industrial applications. Following sale of Unipath, he had a role in Life Sciences as science leader biotechnology with a focus on intervention technologies for a range of HPC categories and a wider range of bio based materials. Also during this time he jointly established a spin out company with Unilever Ventures for applications of biomolecules in the pharmaceutical and agrochemical industry. In 2005 / 06 Neil moved to the Unilever Port Sunlight R&D lab to lead the Biotechnology expertise and science area with closer business and open innovation partner interactions and support the categories in advancing new technologies. His current teams comprise of both scientists located internally and externally with collaborators. In 2012, Neil took on the additional R&D programme director role leading Biotechnology & Biosourcing. This has the strong bias in the discovery for new biotechnologies and green chemistries for opportunities in Unilever’s portfolio. Neil is an inventor on 30+ patents and holds posts on external advisory boards in Industrial Biotechnology (European Union etc).

Babette is Business Development Director at Ginkgo Bioworks. Ginkgo Bioworks is the organism company that designs custom microbes for customers across multiple markets. They build their foundries to scale the process of organism engineering using software and hardware automation. Organism engineers at Ginkgo learn from nature to develop new organisms that replace technology with biology.

Marcel van Berkel studied Chemistry and Business Administration in Utrecht, The Netherlands. He worked for more than 20 years for corporate companies like Solvay and DSM. Marcel left DSM a few years back to expedite the growth of a start-up in the bio-based chemicals industry. After completing this successfully, he started his own consultancy firm VanBerkel Consultancy. With experience in business development, business strategy, marketing & branding and business management, VanBerkel Consultancy offers support in defining and executing your business development and market strategy and can help companies expand to oversees areas.